Insider filing · CADL
Francesca Barone
Chief Scientific Officer
profile →
Candel Therapeutics, Inc.
CADL · Healthcare · 17 filings in 24 months
ticker →
Francesca Barone sold $282K of Candel Therapeutics (CADL)
Executed Mar 18 2025, disclosed Mar 20 2025, 2 days later.
Value, as filed
$282K
32,146 sh × $8.76
Executed
Mar 18 2025
the trade date, as filed
Disclosed
Mar 20 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
FBFrancesca Barone (Chief Scientific Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Candel Therapeutics, Inc. (CADL). The largest single filing was $236K of CADL (23,447 sh × $10.06, as filed), executed Jun 29.
The name
CADLHealthcare · Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Francesca Barone in CADL
CADLSALE
Candel Therapeutics, Inc.
$236K23,447 sh × $10.06
Exec Jun 29
Filed Jul 1 · 4:22 PM ET CADLSALE Candel Therapeutics, Inc. $112K
13,673 sh × $8.22
Exec Jan 8 2025
Filed Jan 10 2025 · 5:30 PM ET CADLSALE Candel Therapeutics, Inc. $101K
22,081 sh × $4.56
Exec Nov 29 2024
Filed Dec 3 2024 · 5:30 PM ET